Výsledky vyhľadávania - "Piubello, Alberto"

Proposal for a standardised treatment regimen to manage pre- and extensively drug-resistant tuberculosis cases Autor Caminero, Jose A, Piubello, Alberto, Scardigli, Anna, Migliori, Giovanni Battista

Zistit podrobnosti o prístupe

Safety of single-dose bedaquiline combined with rifampicin for leprosy post-exposure prophylaxis: A Phase 2 randomized non-inferiority trial in the Comoros Islands Autor de Jong, Bouke Catherine, Nourdine, Said, Bergeman, Auke Thomas, Salim, Zahara, Grillone, Silahi Halifa, Braet, Sofie Marijke, Wirdane Abdou, Mohamed, Snijders, Rian, Ronse, Maya, Hoof, Carolien, Tsoumanis, Achilleas, Ortuño-Gutiérrez, Nimer, der Werf, Christian van, Piubello, Alberto, Mzembaba, Aboubacar, Assoumani, Younoussa, Hasker, Epco

“…To reduce leprosy risk in contacts of patients with leprosy by around 50%, the World Health Organization (WHO) recommends leprosy post-exposure prophylaxis…”
Získať plný text

Bedaquiline: how better to use it Autor Caminero, Jose A, Piubello, Alberto, Scardigli, Anna, Migliori, Giovanni Battista

Zistit podrobnosti o prístupe

High rate of adverse drug reactions with a novel tuberculosis re-treatment regimen combining triple doses of both isoniazid and rifampicin Autor Souleymane, Mahamadou Bassirou, Kadri, Sani, Piubello, Alberto, Tsoumanis, Achilleas, Soumana, Alphazazi, Issa, Hamidou, Amoussa, Abdoulaziz Kabirou, Van Deun, Armand, Lynen, Lutgarde, de Jong, Bouke Catherine, Decroo, Tom

“…•Triple-dose rifampicin is known to be safe for tuberculosis treatment.•Triple-dose isoniazid is known to be safe for tuberculosis treatment.•A triple dose of…”
Získať plný text

Protocol, rationale and design of BE-PEOPLE (Bedaquiline enhanced exposure prophylaxis for LEprosy in the Comoros): a cluster randomized trial on effectiveness of rifampicin and bedaquiline as post-exposure prophylaxis of leprosy contacts Autor Younoussa, Assoumani, Samidine, Said Nourdine, Bergeman, Auke T., Piubello, Alberto, Attoumani, Nissad, Grillone, Silahi Halifa, Braet, Sofie Marijke, Tsoumanis, Achilleas, Baco, Abdallah, Mzembaba, Aboubacar, Salim, Zahara, Amidy, Mohamed, Grillone, Saverio, Snijders, Rian, Corstjens, Paul, Ortuno-Gutierrez, Nimer, Hoof, Carolien, Geluk, Annemieke, de Jong, Bouke C., Hasker, Epco

“…Background Leprosy is an ancient infectious disease with an annual global incidence of around 200,000 over the past decade. Since 2018, the World Health…”
Získať plný text

Treatment outcomes for multidrug- and rifampicin-resistant tuberculosis in Central and West Africa: a systematic review and meta-analysis Autor Toft, Asbjørn Langeland, Dahl, Victor Næstholt, Sifna, Armando, Ige, Olusoji Mayowa, Schwoebel, Valérie, Souleymane, Mahamadou Bassirou, Piubello, Alberto, Wejse, Christian

“…•Multidrug-resistant/rifampicin-resistant tuberculosis remains a major threat to global health, mainly in low-income settings.•We found a successful treatment…”
Získať plný text

Safety, effectiveness, and adherence of a short and all-oral treatment regimen for the treatment of rifampicin-resistant tuberculosis in Niger: a study protocol of a pragmatic randomised clinical trial with stratified block randomisation Autor Souleymane, Mahamadou Bassirou, Decroo, Tom, Soumana, Alphazazi, Maman Lawan, Ibrahim, Gagara-Issoufou, Assiatou, Halidou-Moussa, Souleymane, Ortuño-Gutiérrez, Nimer, Adehossi, Eric, Mamadou, Saïdou, Van Deun, Armand, Piubello, Alberto

“…Background Rifampicin-resistant tuberculosis (RR-TB) treatment requires combination treatment, which frequently causes serious adverse events and globally…”
Získať plný text

Should gatifloxacin be included in the model list of essential medicines? Autor Chiang, Chen-Yuan, Trébucq, Arnaud, Piubello, Alberto, Rieder, Hans L, Van Deun, Armand

Zistit podrobnosti o prístupe

Programmatic management of rifampicin-resistant tuberculosis with standard regimen in Cameroon: a retrospective cohort study Autor Jouego, Christelle Géneviève, Gils, Tinne, Piubello, Alberto, Mbassa, Vincent, Kuate, Albert, Ngono, Annie, Belinga, Edwige, Etoundi, Antoine, Tollo, Alphonse, Makondi, Danielle, André, Emmanuel, Masumbe, Palmer, Lynen, Lutgarde, Noeske, Jürgen, Decroo, Tom

“…To describe treatment outcomes for rifampicin-resistant tuberculosis (Rr-TB) started on standard regimen and the frequency of acquired drug resistance in…”
Získať plný text

Feasibility and accuracy of mobile QT interval monitoring strategies in bedaquiline‐enhanced prophylactic leprosy treatment Autor Bergeman, Auke T., Nourdine, Said, Piubello, Alberto, Salim, Zahara, Braet, Sofie M., Baco, Abdallah, Grillone, Silahi H., Snijders, Rian, Hoof, Carolien, Tsoumanis, Achilleas, Loen, Harry, Assoumani, Younoussa, Mzembaba, Aboubacar, Ortuño‐Gutiérrez, Nimer, Hasker, Epco, Werf, Christian, Jong, Bouke C.

“…Some anti‐mycobacterial drugs are known to cause QT interval prolongation, potentially leading to life‐threatening ventricular arrhythmia. However, the highest…”
Získať plný text

Risk factors for rifampicin resistance tuberculosis among patients attending Directly Observed Treatments Centres in Southwestern Nigeria Autor Cadmus, Simeon, Akinseye, Victor Oluwatoyin, Olagunju, Temitayo, Makolo, Angela, Falodun, Olutayo, Lawal, Oluwole, Babalola, John, Cadmus, Eniola, Yasir, Othman, Fadeyi, Muse, Ahmed, Bolaji, Piubello, Alberto, Ortuno Guiterrez, Nimer, El-Tayeb, Osman

“…tuberculosis (TB) remains a disease of global health importance. GeneXpert has emerged as a useful tool for the diagnosis of drug resistant TB (DR-TB). We…”
Získať plný text

Impact of COVID-19 on diagnosis of tuberculosis and tuberculosis infection in South America, Asia, and Africa Autor Rossato Silva1, Denise, Centis2, Rosella, D’Ambrosio3, Lia, Carvalho de Queiroz Mello4, Fernanda, Rodrigues Pereira5, Giovana, Aguirre6, Sarita, Al-Abri7, Seif, Al-Thohli7, Khalsa, Al Yaquobi8, Fatma, Calnan9, Marianne, Coronel Teixeira10, Rosarito, Inwentarz11, Sandra, Juan Palmero11, Domingo, Piubello12, Alberto, Sharma13, Samridhi, Bassirou Souleymane14, Mahamadou, Soumana15, Alphazazi, Meng Tham16, Sai, Min Thong17, Pei, F Udwadia13, Zarir, van den Boom18, Martin, Sotgiu19, Giovanni, Battista Migliori2, Giovanni

Získať plný text

Outcomes of a nine-month regimen for rifampicin-resistant tuberculosis up to 24 months after treatment completion in nine African countries Autor Schwœbel, Valérie, Trébucq, Arnaud, Kashongwe, Zacharie, Bakayoko, Alimata S., Kuaban, Christopher, Noeske, Juergen, Harouna, Souleymane H., Souleymane, Mahamadou B., Piubello, Alberto, Ciza, François, Fikouma, Valentin, Gasana, Michel, Ouedraogo, Martial, Gninafon, Martin, Van Deun, Armand, Tagliani, Elisa, Cirillo, Daniela M., Koura, Kobto G., Rieder, Hans L.

“…Treatment outcomes of the shorter regimen for rifampicin-resistant tuberculosis are not completely established. We report on these outcomes two years after…”
Získať plný text

Shifts in Mycobacterial Populations and Emerging Drug-Resistance in West and Central Africa Autor Gehre, Florian, Ejo, Mebrat, Fissette, Kristina, de Rijk, Pim, Uwizeye, Cécile, Nduwamahoro, Elie, Goovaerts, Odin, Affolabi, Dissou, Gninafon, Martin, Lingoupou, Fanny M., Barry, Mamadou Dian, Sow, Oumou, Merle, Corinne, Olliaro, Piero, Ba, Fatoumata, Sarr, Marie, Piubello, Alberto, Noeske, Juergen, Antonio, Martin, Rigouts, Leen, de Jong, Bouke C

“…In this study, we retrospectively analysed a total of 605 clinical isolates from six West or Central African countries (Benin, Cameroon, Central African…”
Získať plný text

Dr Georges Bakaswa Ntambwe, 1950-2016 Autor Piubello, Alberto

Zistit podrobnosti o prístupe

Tuberculosis and COVID-19 co-infection: description of the global cohort

“…Information on tuberculosis (TB) and coronavirus disease 2019 (COVID-19) is still limited. The aim of this study was to describe the features of the…”
Zistit podrobnosti o prístupe

High-Dose First-Line Treatment Regimen for Recurrent Rifampicin-Susceptible Tuberculosis Autor Decroo, Tom, de Jong, Bouke C, Piubello, Alberto, Souleymane, Mahamadou Bassirou, Lynen, Lutgarde, Van Deun, Armand

Zistit podrobnosti o prístupe

Standardised shorter regimens versus individualised longer regimens for rifampin- or multidrug-resistant tuberculosis Autor Abidi, Syed, Achar, Jay, Assao Neino, Mourtala Mohamed, Bang, Didi, Benedetti, Andrea, Brode, Sarah, Campbell, Jonathon R, Casas, Esther C, Conradie, Francesca, Dravniece, Gunta, du Cros, Philipp, Falzon, Dennis, Jaramillo, Ernesto, Kuaban, Christopher, Lan, Zhiyi, Lange, Christoph, Li, Pei Zhi, Makhmudova, Mavluda, Maug, Aung Kya Jai, Menzies, Dick, Migliori, Giovanni Battista, Miller, Ann, Myrzaliev, Bakyt, Ndjeka, Norbert, Noeske, Jürgen, Parpieva, Nargiza, Piubello, Alberto, Schwoebel, Valérie, Sikhondze, Welile, Singla, Rupak, Souleymane, Mahamadou Bassirou, Trébucq, Arnaud, Van Deun, Armand, Viney, Kerri, Weyer, Karin, Zhang, Betty Jingxuan, Ahmad Khan, Faiz

“…We sought to compare the effectiveness of two World Health Organization (WHO)-recommended regimens for the treatment of rifampin- or multidrug-resistant…”
Zistit podrobnosti o prístupe

The future of drug-resistant tuberculosis treatment: learning from the past and the 2019 World Health Organization consolidated guidelines Autor Caminero, José A, García-Basteiro, Alberto L, Rendon, Adrián, Piubello, Alberto, Pontali, Emanuele, Migliori, Giovanni Battista

Zistit podrobnosti o prístupe

The looming threat of bedaquiline resistance in tuberculosis Autor Chiang, Chen-Yuan, Trébucq, Arnaud, Piubello, Alberto, Rieder, Hans L, Schwoebel, Valérie, Van Deun, Armand

Zistit podrobnosti o prístupe